Abstract Tjeerdsma G, Sluiter WJ, Hew JM, Molenaar WM, de Lange WE, Dullaart RPF.
Hyperprolactinaemia is associated with a higher prevalence of pituitary—adrenal …

Objective: The prevalence of hyperprolactinemia in non-functioning pituitary
macroadenomas (NFPMAs) is not well known, and hyperprolactinemia caused by a NFPMA …

The objective of this study was to evaluate characteristics that discriminate prolactinoma
from non-functioning pituitary macroadenoma with hyperprolactinemia. We included 117 …

Objective: Serum PRL levels at presentation may be useful in distinguishing between
disconnection hyperprolactinemia in non-secretory pituitary adenomas and prolactinomas in …

Background The differentiation of a pituitary non‐functioning macroadenoma from a
macroprolactinoma is important for planning appropriate therapy. Serum PRL levels have …

Hyperprolactinemia is a prevalent endocrine disorder presented in patients with non-
functional pituitary adenomas (NFPAs). However, the mechanism involved in …

OBJECTIVE Hyperprolactinaemia in humans may be associated with a high prevalence of
obesity but the nature of this link is poorly defined. The aim of this study was to establish the …

Background/Aims: Hyperprolactinaemia is a common cause of amenorrhoea due to
hypogonadotropic hypogonadism. Prolactin is hypothesised to impede the reproductive axis …

objective We have assessed whether in‐situ hybridization for prolactin messenger RNA
(mRNA) provides additional Information for the classification of pituitary macroadenomas …

In 32 patients with macroprolactinomas or functionless pituitary macroadenomas
biochemical and clinical data were correlated with PRL immunocytochemistry. Serum PRL …